1Lipinski C A. Drug like properties and the causes of poor solubili- ty and poor permeability [ J]. J Pharmacol Toxlcol Methods, 2000, 44 (1) : 235 -249.
2Rao G C, Kumar M S, Mathivanan N, et al. Nanosuspensions as the most promising approach in nanoparticulate drug delivery sys- tems[J]. Pharmazie, 2004, 59(1 ): 5-9.
3Patravale V B, Date A A, Kulkarni R M. Nanosuspensions: a promising drug delivery strategy [ J ]. J Pharm Pharmcol, 2004, 56 (7) : 827 - 840.
4Cornelia M K, Rainer H M. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation [ J ]. Eur J PharmBiopharm, 2006, 62( 1 ): 3- 16.
7Indrajit G, Sonali B, Radha V, et al. Nanosuspension for impro- ving the bioavailability of a poor soluble drug and screening of sta- bilizing agents to inhibit crystal growth [ J ]. Int J Pharm, 2011, 409 ( 1 - 2) : 260 - 268.
8Xiong R, Lu W, Li J, et al. Preparation and characterization of intravenously injectable nimodipine nanosuspension [ J ]. Int J Pharm, 2008, 350(1 -2) : 338 -343.
9Swamali D, Mpharm, Suresh PK, et al. Nanosuspension: a new vehicle for the improvement of the delivery of drags to the ocular surface. Application to amphotericin B [ J ]. Nanomedicine : Nano- technology, Biology, and Medicine, 2011, 7(2) : 242-247.
10Shin M S, Lee Y, Kim H, et al. Method for preparing nanoparti- cles comprising vitamin K and poly - isopropyl - butyl methacry- late - acrylic acid copolymer with supercritical fluid using molecu- lar association theory : US ,20080152715 (AI) [ P], 2008 -06 - 26.
4O'Driscoll C M,Griffin B T. Biopharmaceutical challenges associated with drugs with low aqueous solubility-the potential impact of lipid-based formulations[J]. Adv Drug Deliv Rev,2008,60(6) :617-624.
5Hauss D J. Oral lipid-based formulations[J]. Adv Drug Deliv Rev,2007,59(7) :667-676.
6Serajuddin A T. Salt formation to improve drug solubility[J]. Adv Drug Deliv Rev,2007,59(7):603-616.
7Kesisoglou F,Panmai S, Wu Yun hui. Nanosizing-oral formulation developmem and biopharmaceutical evaluation[J].Adv Drug Deliv Rev,2007,59(7) : 631-644.
8Amidon G L,Lennernas H,Shah V P,et al. A theoretical basis for a biopharmaceutic drug classification:the correlation of in vitro drug product dissolution and in vivo bioavailability[J].Pharm Res,1995,12(3) :413-420.
9Stella V J, Nti-Addae K W. Prodrug strategies to overcome poor water solubility[J]. Adv Drug Deliv Rev, 2007,59(7):677-694.
10Brewster M E, Loftsson T. Cyclodextrins as pharmaceutical solubilizers[J]. Adv Drug Deliv Rev, 2007,59(7) :645-666.
